PharmDBull

HIV Pharmacist. OTC Swing Trader.

[PharmDBull @m3power326]

@stock_hacker Right. I hate apparel mergers. They’re always garbage which sucks considering the low float.

[PharmDBull @m3power326]

@STNorth19 Can only buy on non-US brokers right?

[PharmDBull @m3power326]

$TNFA

[Lycanbull @Lycanbull]

$TNFA TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation
https://t.co/foSsVSj4fy

[PharmDBull @m3power326]

$TNFA good until Sept 15

[PharmDBull @m3power326]

$HMBL #AI #otc

[Thiago Moura e Silva @EuThiago_Moura]

HUMBL, Inc. Announces Unwinding of Share Exchange Agreement with NUBURU, Inc.

Our focus now is on AI !

https://t.co/dXFpyfbkcT

[PharmDBull @m3power326]

@LunaClassicBoss @PBInvesting It’s now HMBL. Rode the hype train from 0.02 to 1.80 and then back down again during Covid.

[PharmDBull @m3power326]

@TheStockDon You figure the Hemopurifier can remove virus from the milk? Or how does AEMD fit in?

[PharmDBull @m3power326]

@EStock1324 I still have mine. Who doesn’t love the reminder of taking $2000 to $180k to zero 😆

[PharmDBull @m3power326]

$SLDC 307m OS with 131m unrestricted.

[PharmDBull @m3power326]

$JNSH 317m OS. ICC certified EV charging stations installer. No promissory or convertible notes and no new shares issued in the last 2-3+ years

[PharmDBull @m3power326]

@JoshRasch 😆

[PharmDBull @m3power326]

$ATNM needs to pull a $IMGN

[PharmDBull @m3power326]

@TreyHaskins @PBInvesting It’s going to go up typically

[PharmDBull @m3power326]

@hqxkxbuzzkiller @FSTrades Those were the days.

[PharmDBull @m3power326]

@Phred_Bear @cdntradegrljenn Why so far out?

[PharmDBull @m3power326]

$QBAND I didn’t catch what the OS was before the RS. Anyone know what the new OS is? OTCM hasn’t updated it yet.

[PharmDBull @m3power326]

@THE_DrAnderson That’s weird it doesn’t have a photo of you on there.

[PharmDBull @m3power326]

$ATNM

[Michael Bigger @biggercapital]

Amazing $ATNM•22% of patients (13/59) achieved dCR on the SIERRA arm compared to 0% of patients on the control arm •Patients who achieved 6-month dCR had 92% 1-year survival and 60% 2-year survival Median OS has not been reached in these patients

[PharmDBull @m3power326]

@HEV4th @HarringtonKevin Lmao

[PharmDBull @m3power326]

@TAPINTARIN $AFTM lol